{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:54:21Z","timestamp":1782489261099,"version":"3.54.5"},"reference-count":29,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009131","name":"Swiss Agency for Development and Cooperation","doi-asserted-by":"crossref","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Glycated haemoglobin A1c (HbA1c) measurement is essential for managing diabetes, yet limited data exist on the performance of point-of-care (POC) HbA1c devices in low- and middle-income countries (LMICs). This study evaluated the analytical performance and usability of HbA1c devices in different LMIC settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design and setting<\/jats:title>\n                    <jats:p>This prospective, cross-sectional multicentre study evaluated the accuracy and usability of four POC devices (i-SENS A1Care, HemoCue HbA1c 501 System, Abbott Afinion 2 and Siemens DCA Vantage) against a laboratory-based HbA1c method at two hospitals in Nigeria and Cambodia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults with or without diabetes and haemoglobin \u22658\u2009g\/dL were enrolled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>The primary objective was to evaluate HbA1c POC device accuracy versus laboratory reference testing; secondary objectives evaluated device usability and technical characteristics when used by trained professionals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>Capillary and venous blood samples were tested on all devices using two cartridge lots followed by reference testing. Usability was assessed via operator questionnaires. Accuracy was evaluated using regression slopes, intercept, absolute bias at 30, 48 and 75\u2009mmol\/mol, and Bland-Altman analysis, including capillary-venous concordance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 248 participants completed all study procedures (n=125 in Cambodia, n=123 in Nigeria). Siemens DCA Vantage and Abbott Afinion 2 showed strong agreement with the reference method, with no clinically significant differences and narrow limits of agreement. In contrast, i-SENS A1Care and HemoCue HbA1c 501 System displayed greater bias, especially at elevated HbA1c levels. Most results fell within limits of agreement, though high-HbA1c outliers were more common with the A1Care and HbA1c 501 System devices. Usability feedback was positive overall, when devices were rated across various dimensions, such as clarity of instructions, safety and labelling, although limited user sample size constrains the generalisability of these findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Siemens DCA Vantage and Abbott Afinion 2 demonstrated reliable accuracy and usability. In contrast, i-SENS A1Care and HemoCue HbA1c 501 System require cautious interpretation at high HbA1c levels. Ongoing evaluation is critical to ensure the appropriate use of POC devices in diverse clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06170515\">NCT06170515<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-113491","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:26:07Z","timestamp":1778599567000},"page":"e113491","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Analytical performance of four HbA1c point-of-care devices: a cross-sectional evaluation in low- and middle-income countries"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06170515","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06170515","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-7907","authenticated-orcid":false,"given":"Priyanka","family":"Singh","sequence":"first","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-2873","authenticated-orcid":false,"given":"Erna","family":"Lenters-Westra","sequence":"additional","affiliation":[{"name":"European Reference Laboratory for Glycohemoglobin, Zwolle, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimcheng","family":"Choun","sequence":"additional","affiliation":[{"name":"Sihanouk Hospital Center of Hope, Phnom Penh, Cambodia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7172-7053","authenticated-orcid":false,"given":"Olufemi","family":"Fasanmade","sequence":"additional","affiliation":[{"name":"College of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1152-6772","authenticated-orcid":false,"given":"Berra","family":"Erkosar","sequence":"additional","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-1643","authenticated-orcid":false,"given":"Mikaela","family":"Watson","sequence":"additional","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Haldane","sequence":"additional","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Vetter","sequence":"additional","affiliation":[{"name":"FIND, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2026062608321428000_16.5.e113491.1","unstructured":"World Health Organization . Diabetes. 2024. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes"},{"key":"2026062608321428000_16.5.e113491.2","unstructured":"International Diabetes Federation . facts & figures. 2025. Available: https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/ [Accessed 14 Mar 2025]."},{"key":"2026062608321428000_16.5.e113491.3","unstructured":"FIND . Landscape of point-of-care devices for testing of cardiometabolic diseases 2022. 2025."},{"key":"2026062608321428000_16.5.e113491.4","unstructured":"World Health Organization . The selection and use of essential in vitro diagnostics. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/373322\/9789240081093-eng.pdf [Accessed 19 Feb 2024]."},{"key":"2026062608321428000_16.5.e113491.5","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S006"},{"key":"2026062608321428000_16.5.e113491.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291401"},{"key":"2026062608321428000_16.5.e113491.7","unstructured":"Eyth E, R N . Hemoglobin a1c: statpearls. 2025."},{"key":"2026062608321428000_16.5.e113491.8","unstructured":"World Health Organization . WHO package of essential noncommunicable (pen) disease interventions for primary health care 2020. 2020 Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/334186\/9789240009226-eng.pdf?sequence=1"},{"key":"2026062608321428000_16.5.e113491.9","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0040"},{"key":"2026062608321428000_16.5.e113491.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-021-02298-7","article-title":"Development of a target product profile for a point-of-care cardiometabolic device","volume":"21","author":"Vetter","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"2026062608321428000_16.5.e113491.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2005.08.001"},{"key":"2026062608321428000_16.5.e113491.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101092","article-title":"Point-of-care diagnostics for infectious diseases: From methods to devices","volume":"37","author":"Wang","year":"2021","journal-title":"Nano Today"},{"key":"2026062608321428000_16.5.e113491.13","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2014.224311"},{"key":"2026062608321428000_16.5.e113491.14","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2009.130641"},{"key":"2026062608321428000_16.5.e113491.15","first-page":"375","article-title":"Prevention and control of haemoglobinopathies","volume":"73","author":"Angastiniotis","year":"1995","journal-title":"Bull World Health Organ"},{"key":"2026062608321428000_16.5.e113491.16","first-page":"704","article-title":"Inherited haemoglobin disorders: an increasing global health problem","volume":"79","author":"Weatherall","year":"2001","journal-title":"Bull World Health Organ"},{"key":"2026062608321428000_16.5.e113491.17","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/39.3.424"},{"key":"2026062608321428000_16.5.e113491.18","unstructured":"World Health Organization . Technical specifications series for submission to who prequalification\u2013 diagnostic assessment 2022. 2022. Available: https:\/\/extranet.who.int\/prequal\/sites\/default\/files\/document_files\/Draft_TSS_18_HbA1c_POC.pdf"},{"key":"2026062608321428000_16.5.e113491.19","unstructured":"FIND . Call for partners for supply of point-of-care glycated hemoglobin (hba1c) analysers and tests for low- and middle-income countries via the find dxconnect marketplace. 2021. Available: https:\/\/archive.finddx.org\/wp-content\/uploads\/2021\/09\/FIND-Call-for-Partners_POC-HbA1c_3-Sept-1.pdf"},{"key":"2026062608321428000_16.5.e113491.20","unstructured":"FIND . Partners with manufacturers to improve affordability and access to point-of-care hba1c testing in low- and middle-income countries. 2023. Available: https:\/\/www.finddx.org\/publications-and-statements\/press-release\/find-partners-with-manufacturers-to-improve-affordability-and-access-to-point-of-care-hba1c-testing-in-low-and-middle-income-countries\/#:~:text=HbA1c%20testing%20is%20key%20to,%2Dof%2Dcare%20cardiometabolic%20device"},{"key":"2026062608321428000_16.5.e113491.21","unstructured":"International Federation of Clinical Chemistry . List reference laboratories. Available: https:\/\/www.ifcchba1c.org\/GeneralInformation.aspx?I=9 [Accessed 6 May 2025]."},{"key":"2026062608321428000_16.5.e113491.22","unstructured":"NGSP . NGSP network laboratory members. n.d. Available: https:\/\/ngsp.org\/network.asp"},{"key":"2026062608321428000_16.5.e113491.23","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2014.235333"},{"key":"2026062608321428000_16.5.e113491.24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1515\/cclm-2020-1308","article-title":"Are hemoglobin A1c point-of-care analyzers fit for purpose? The story continues","volume":"59","author":"Lenters-Westra","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"2026062608321428000_16.5.e113491.25","unstructured":"World Health Organization . Designing instructions for use for in vitro diagnostic medical devices. 2017. Available: https:\/\/iris.who.int\/handle\/10665\/259737 [Accessed 18 Jul 2025]."},{"key":"2026062608321428000_16.5.e113491.26","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare11131887","article-title":"Retaining Healthcare Workers: A Systematic Review of Strategies for Sustaining Power in the Workplace","volume":"11","author":"De Vries","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"2026062608321428000_16.5.e113491.27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/cclm-2016-0303","article-title":"Performance of point-of-care HbA 1c test devices: implications for use in clinical practice \u2013 a systematic review and meta-analysis","volume":"55","author":"Hirst","year":"2017","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"2026062608321428000_16.5.e113491.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003760","article-title":"Performance and usability of cardiometabolic point of care devices in Nepal: A prospective, quantitative, accuracy study","volume":"4","author":"Giachino","year":"2024","journal-title":"PLOS Glob Public Health"},{"key":"2026062608321428000_16.5.e113491.29","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/clinchem\/hvaf059","article-title":"Challenges in Hb A1c Point-of-Care Testing: Only 5 of 19 Hb A1c Point-of-Care Devices Meet IFCC and NGSP Certification Criteria on Independent Evaluation","volume":"71","author":"Lenters-Westra","year":"2025","journal-title":"Clin Chem"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-113491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:44:51Z","timestamp":1782488691000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-113491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,12]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/bmjopen-2025-113491"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-113491","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}